5201 - 5210 of 7665 Results
Title
Year
- Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease2018RESTRICTEDTitle: Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1286-2Best OA location URL: https://doi.org/10.1186/s12974-018-1286-2Citation Count: 65
-
RESTRICTEDTitle: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s diseaseJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 215Issue #: 9Start Page: 2247End Page: 2264Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20180484Best OA location URL: https://rupress.org/jem/article-pdf/215/9/2247/1171465/jem_20180484.pdfCitation Count: 53
- Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorder2018RESTRICTEDTitle: Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorderJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 13Issue #: 5Start Page: 1352End Page: 1360Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11682-018-9939-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11682-018-9939-4.pdfCitation Count: 23
- Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins2018RESTRICTEDTitle: Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteinsJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745680Best OA location URL: https://doi.org/10.15252/embr.201745680Citation Count: 43
-
RESTRICTEDTitle: Increased substantia nigra echogenicity in LRRK2 family members without mutationsJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 9Start Page: 1504End Page: 1505Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27443Best OA location URL: https://europepmc.org/articles/pmc6346431?pdf=renderCitation Count: 1
-
RESTRICTEDTitle: Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1601End Page: 1608Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27362Citation Count: 178
- Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy2018RESTRICTEDTitle: Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and SynucleinopathyJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 5Start Page: 3476End Page: 3483Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1313-4Citation Count: 22
- Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy2018RESTRICTEDTitle: Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 5Start Page: 709End Page: 727Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-018-1900-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-018-1900-5.pdfCitation Count: 48
- Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model2018RESTRICTEDTitle: Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease modelJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0062-4Best OA location URL: https://www.nature.com/articles/s41531-018-0062-4.pdfCitation Count: 62
-
RESTRICTEDTitle: Cognition among individuals along a spectrum of increased risk for Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 8Start Page: e0201964End Page: e0201964Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0201964Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0201964&type=printableCitation Count: 31